BAMCO Inc
SAGE

BAMCO Inc’s Sage Therapeutics SAGE Stock Holding History

BAMCO Inc’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-414,122
Closed -$29.9M – 359
2019
Q4 		$29.9M Sell
414,122
-11,534
-3% -$1.42M 0.11% 142
2019
Q3 		$59.7M Buy
425,656
+692
+0.2% +$116K 0.25% 94
2019
Q2 		$77.8M Sell
424,964
-5,606
-1% -$957K 0.31% 75
2019
Q1 		$68.5M Buy
430,570
+89,261
+26% +$12.9M 0.29% 84
2018
Q4 		$32.7M Buy
341,309
+19,713
+6% +$2.26M 0.17% 128
2018
Q3 		$45.4M Buy
321,596
+52,053
+19% +$8.03M 0.19% 120
2018
Q2 		$42.2M Buy
269,543
+86,280
+47% +$13.5M 0.18% 122
2018
Q1 		$29.5M Buy
183,263
+95,140
+108% +$16.2M 0.14% 146
2017
Q4 		$14.5M Sell
88,123
-5,335
-6% -$517K 0.07% 190
2017
Q3 		$5.82M Buy
93,458
+11,434
+14% +$898K 0.03% 220
2017
Q2 		$6.53M Buy
82,024
+4,514
+6% +$326K 0.03% 214
2017
Q1 		$5.51M Sell
77,510
-10,810
-12% -$633K 0.03% 219
2016
Q4 		$4.51M Buy
88,320
+14,989
+20% +$707K 0.03% 214
2016
Q3 		$3.38M Buy
73,331
+26,455
+56% +$1.08M 0.02% 227
2016
Q2 		$1.41M Buy
46,876
+40,472
+632% +$1.35M 0.01% 254
2016
Q1 		$205K Hold
6,404
– – ﹤0.01% 283
2015
Q4 		$373K Sell
6,404
-7,096
-53% -$352K ﹤0.01% 292
2015
Q3 		$571K Buy
13,500
+6,000
+80% +$370K ﹤0.01% 325
2015
Q2 		$547K Buy
+7,500
New +$482K ﹤0.01% 341

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BAMCO Inc's SAGE Position: Q1 2020 in Review

BAMCO Inc sold out of Sage Therapeutics (SAGE) in Q1 2020, closing a stake of 414,122 shares — an estimated $29.9M sold.

BAMCO Inc first reported a position in SAGE in Q2 2015 and held it in 19 quarters. The position peaked at $77.8M in Q2 2019. 230 funds tracked by Wall St. Rank hold SAGE as of Q1 2020.

  • BAMCO Inc reported no remaining Sage Therapeutics position as of Q1 2020 after selling out during the quarter.
  • BAMCO Inc sold 414,122 Sage Therapeutics shares in Q1 2020, an estimated $29.9M.
  • BAMCO Inc first reported a position in Sage Therapeutics in Q2 2015 and held it in 19 quarters.
  • BAMCO Inc's Sage Therapeutics position peaked at $77.8M in Q2 2019.
  • 230 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2020.

Based on BAMCO Inc's 13F filing for Q1 2020, filed 15 May 2020.